Manufacturers Life Insurance Company, The Edgewise Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 38,410 shares of EWTX stock, worth $927,601. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,410
Previous 38,366
0.11%
Holding current value
$927,601
Previous $690,000
48.55%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding EWTX
# of Institutions
191Shares Held
100MCall Options Held
2.17MPut Options Held
410K-
Orbimed Advisors LLC San Diego, CA15MShares$363 Million9.45% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$215 Million3.32% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$145 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$141 Million1.67% of portfolio
-
Novo Holdings Hellerup, G75.55MShares$134 Million10.36% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.53B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...